Abstract: A broadband 1-bit reconfigurable transmit-array (TA) featuring independent dual-polarized beam-scanning capability is reported at Ka-band. Bandwidth enhanced transmissive elements based on ...

Phenotypical screening assays involving adherent cell culture are essential for research in cell biology and toxicology as well as drug discovery. Such assays often involve hundreds of culture ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Phenotypical screening assays involving adherent cell culture are essential for ...

Objective: Additional prognostic factors in patients with early-stage oral squamous cell carcinoma (OSCC) may optimize disease staging by identifying patients with high-risk constellations and ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

Cells evolve within intricate, fiber-rich microenvironments that present significant challenges for studying their behavior and mechanics. To address this, we employed advanced three-dimensional (3D) ...

Abstract: Cell-free (CF) massive MIMO (m-MIMO) architectures operating under Rician fading conditions are investigated, with a focus on position-aware signal processing and Bayesian channel estimation ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Indices when accessing an element of a vector from an array of vectors from a Constant Buffer can be incorrect. This appears to be the cause of issues #155919 (10800 test failures) and #155890 (1773 ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

US Food and Drug Administration (FDA) has accepted the company’s Type C meeting request and SKNJCT-003 Phase 2 study has randomized more than 75% of patients Philadelphia, Pennsylvania--(Newsfile Corp ...